Ryan Bartlett


Ryan Bartlett, Ph.D., joined Compass Minerals as vice president, innovation and product development in 2016. Capitalizing on his innovation experience, he was named chief transformation officer in September 2019, and then chief strategy and transformation officer in July 2020. In July 2021, he was named chief strategy officer as he transitioned from leading the company’s enterprise optimization efforts to directing the company’s strategic evaluation of its defined lithium brine resource. Dr. Bartlett continues responsibility for developing corporate strategy and identifying value-enhancing opportunities for the company.  

Prior to joining the company, Dr. Bartlett spent 10 years working at Monsanto Company, a global provider of agricultural products, where he led the discovery and development of next generation transgenic traits and agricultural biologicals. He is also a fifth-generation owner of his family farm and ranch in central Kansas.

Dr. Bartlett holds a Bachelor of Science in genetics and a doctorate in biochemistry and biophysics from the University of Kansas. He completed his postdoctoral studies at the Vanderbilt University Medical Center on protein interactions related to Parkinson’s and cardiovascular diseases. He is the author and co-author of numerous publications in the fields of biochemistry, biophysics and cell biology.